Lafond Kevin G 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 2, 2019
Insider Transaction Report
Form 4
Lafond Kevin G
Vice Pres., Treasurer, & CAO
Transactions
- Tax Payment
Common Stock
2018-12-30$1.66/sh−13,100$21,746→ 57,767 total - Tax Payment
Common Stock
2018-12-29$1.66/sh−17,667$29,327→ 70,867 total - Tax Payment
Common Stock
2018-12-31$1.87/sh−9,334$17,455→ 48,433 total
Footnotes (1)
- [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.